TY - JOUR
T1 - Metabolic syndrome and time to pregnancy
T2 - a retrospective study of nulliparous women
AU - Grieger, J. A.
AU - Grzeskowiak, L. E.
AU - Smithers, L. G.
AU - Bianco-Miotto, T.
AU - Leemaqz, S. Y.
AU - Andraweera, P.
AU - Poston, L.
AU - McCowan, L. M.
AU - Kenny, L. C.
AU - Myers, J.
AU - Walker, J. J.
AU - Norman, R. J.
AU - Dekker, G. A.
AU - Roberts, C. T.
PY - 2019/6
Y1 - 2019/6
N2 - Objective: To determine: (1) the association between metabolic syndrome (MetS), time to pregnancy (TTP), and infertility; (2) associations between individual and an increasing number of MetS components, TTP, and infertility; and (3) whether these relationships differ by body mass index (BMI < 30 kg/m2 versus BMI ≥ 30 kg/m2). Design: Retrospective cohort study. Setting: Multiple centres (in Australia, Ireland, New Zealand, and the UK). Population: Five thousand five hundred and nineteen low-risk nulliparous pregnant women. Methods: Data on retrospectively reported TTP (number of months to conceive) and a blood sample to assess metabolic health were collected between 14 and 16 weeks of gestation. MetS was defined according to the International Diabetes Federation criteria. Accelerated failure time models with log-normal distribution were conducted to estimate time ratios (TRs) and 95% CIs. Differences in MetS on infertility (TTP > 12 months) were compared using a generalised linear model (Poisson distribution) with robust variance estimates (relative risks, RRs; 95% CIs). All analyses (entire cohort and split by BMI) were controlled for a range of maternal and paternal confounding factors. Main outcome measures: Time to pregnancy and infertility. Results: Of the 5519 women included, 12.4% (n = 684) had MetS. Compared with women without MetS, women with MetS had a longer TTP (adjusted TR 1.30; 95% CI 1.15–1.46), which was similar in women who were obese and in women who were not obese. Marginal estimates for median TTP in women with MetS versus without MetS was 3.1 months (3.0–3.3 months) versus 4.1 months (3.6–4.5 months), respectively. Women with MetS were at a 62% greater risk for infertility and were at a greater risk for infertility whether they were obese (adjusted RR 1.62; 95% CI 1.15–2.29) or not (adjusted RR 1.73; 95% CI 1.33–2.23). Reduced high-density lipoprotein cholesterol (HDL-C) and raised triglycerides (TGs) were the main individual components associated with risk for infertility. Conclusion: Metabolic syndrome is associated with longer TTP and infertility, independent of obesity. Additional studies, before pregnancy, are required to support our findings and to determine the applicability of which combinations of metabolic abnormalities pose the greatest risk to delayed fertility, or whether individual components are amenable to modification. Tweetable abstract: Metabolic syndrome is associated with longer time to pregnancy and infertility, independent of obesity.
AB - Objective: To determine: (1) the association between metabolic syndrome (MetS), time to pregnancy (TTP), and infertility; (2) associations between individual and an increasing number of MetS components, TTP, and infertility; and (3) whether these relationships differ by body mass index (BMI < 30 kg/m2 versus BMI ≥ 30 kg/m2). Design: Retrospective cohort study. Setting: Multiple centres (in Australia, Ireland, New Zealand, and the UK). Population: Five thousand five hundred and nineteen low-risk nulliparous pregnant women. Methods: Data on retrospectively reported TTP (number of months to conceive) and a blood sample to assess metabolic health were collected between 14 and 16 weeks of gestation. MetS was defined according to the International Diabetes Federation criteria. Accelerated failure time models with log-normal distribution were conducted to estimate time ratios (TRs) and 95% CIs. Differences in MetS on infertility (TTP > 12 months) were compared using a generalised linear model (Poisson distribution) with robust variance estimates (relative risks, RRs; 95% CIs). All analyses (entire cohort and split by BMI) were controlled for a range of maternal and paternal confounding factors. Main outcome measures: Time to pregnancy and infertility. Results: Of the 5519 women included, 12.4% (n = 684) had MetS. Compared with women without MetS, women with MetS had a longer TTP (adjusted TR 1.30; 95% CI 1.15–1.46), which was similar in women who were obese and in women who were not obese. Marginal estimates for median TTP in women with MetS versus without MetS was 3.1 months (3.0–3.3 months) versus 4.1 months (3.6–4.5 months), respectively. Women with MetS were at a 62% greater risk for infertility and were at a greater risk for infertility whether they were obese (adjusted RR 1.62; 95% CI 1.15–2.29) or not (adjusted RR 1.73; 95% CI 1.33–2.23). Reduced high-density lipoprotein cholesterol (HDL-C) and raised triglycerides (TGs) were the main individual components associated with risk for infertility. Conclusion: Metabolic syndrome is associated with longer TTP and infertility, independent of obesity. Additional studies, before pregnancy, are required to support our findings and to determine the applicability of which combinations of metabolic abnormalities pose the greatest risk to delayed fertility, or whether individual components are amenable to modification. Tweetable abstract: Metabolic syndrome is associated with longer time to pregnancy and infertility, independent of obesity.
KW - Fecundity
KW - infertility
KW - lipids
KW - metabolic syndrome
KW - pregnancy
KW - retrospective study
KW - time to pregnancy
UR - http://www.scopus.com/inward/record.url?scp=85062780758&partnerID=8YFLogxK
UR - http://purl.org/au-research/grants/NHMRC/GNT1099422
U2 - 10.1111/1471-0528.15647
DO - 10.1111/1471-0528.15647
M3 - Article
C2 - 30734474
AN - SCOPUS:85062780758
SN - 1470-0328
VL - 126
SP - 852
EP - 862
JO - BJOG: An International Journal of Obstetrics and Gynaecology
JF - BJOG: An International Journal of Obstetrics and Gynaecology
IS - 7
ER -